New Product Development > New Product Planning

New Product Planning Research



Pharmaceutical New Product Planning: Structure and Activities to Drive Growth and Profitability 
Pharmaceutical and biotech companies are increasingly under pressure to deliver effective new products in shorter time frames while minimizing development costs... (ID PSM-229)
Companies Profiled: Abbott Laboratories, Sanofi-aventis, Actelion, Alcon, more ...
Price: $9000.00   Free Excerpt Available


Pharmaceutical New Product Planning Excellence: Structure & Activities that Drive Profitability & Growth 
Bio-pharmaceutical organizations are under intense pressure to deliver innovative new products in shorter time frames while minimizing development costs... (ID PSM-333)
Companies Profiled: Alkermes, Allergan, Astellas, Bayer, more ...
Price: $8000.00   Free Excerpt Available


Driving Growth Through Planning, Structure and Activities: Best Practices in Pharmaceutical New Product Planning 
New products are the lifeblood of any biopharma company and organizations are increasingly under pressure to deliver effective products in shorter time frames... (ID SM-182)
Companies Profiled: Abbott Laboratories, Sanofi-aventis, Actelion, Alcon, more ...
Price: $7000.00   Free Excerpt Available


Pharmaceutical New Product Planning: Role and Activities for Medical Affairs 
Leading pharmaceutical and biotech companies are increasingly under pressure to deliver effective new products in shorter time frames while minimizing development costs... (ID PSM-249)
Companies Profiled: Abbott Laboratories, Sanofi-aventis, Actelion, Alcon, more ...
Price: $4600.00   Free Excerpt Available


New Product Planning in Pharma: Preparing for the Market 
Long and costly product development cycles make it essential for pharmaceutical companies to maximize limited staff and resources to the development of compounds with the greatest potential market value... (ID PSM-227)
Companies Profiled: Abbott, Allergan, Alexion Pharmaceuticals, Altus Biologics, more ...
Price: $4595.00   Free Excerpt Available


Bolstering Product Portfolios: Resources, Structure and Process for Effective In-licensing Organizations 
Gain insight into how to structure in-licensing organizations, develop processes that facilitate the ability to identify the best opportunities and move smoothly from initial contact to binding agreement... (ID OP-93)
Companies Profiled: AstraZeneca, Sanofi-aventis, Bristol-Myers Squibb, Genentech, more ...
Price: $3328.00   Free Excerpt Available


 

 
ACCESS AND INTELLIGENCE FOR ACHIEVING WORLD-CLASS EXCELLENCE
Quick Links  Product RSS Feed
Payment gateway
Secured by PayPal

Follow Us: 

linkedin twitter slideshare youtube google + pinterest

All contents copyright 1998-2020 Best Practices, LLC (919) 403-0251
Read our Terms and Conditions of Use, Privacy Policy and Copyright Information